EP 0557244 B1 19960313 - Dosage forms having prolonged active-ingredient release
Title (en)
Dosage forms having prolonged active-ingredient release
Title (de)
Darreichungsformen mit verlaengerter Wirkstoffreigabe
Title (fr)
Applications de l'efficacité à longue spectre
Publication
Application
Priority
CH 46992 A 19920217
Abstract (en)
[origin: EP0557244A1] Pharmaceutical dosage forms having a linear release rate of the 0<th> order for the once-daily oral administration of 20 - 120 mg of nifedipine or of another calcium antagonist of the dihydropyridine type, characterised by a homogeneous matrix containing 2 - 50 % by weight of hydroxypropyl-methylcellulose having an average molecular weight of 20,000 - 250,000, 5 - 60 % by weight of a calcium antagonist of the dihydropyridine type, as well as customary excipients compatible with the formulation, such as lipophilic or hydrophilic liberation controllers, fillers, flow-regulating agents, lubricants and, optionally, film coatings. <IMAGE>
IPC 1-7
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/44 (2006.01)
CPC (source: EP)
A61K 9/2004 (2013.01); A61K 9/2054 (2013.01); A61K 31/44 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE
DOCDB simple family (publication)
EP 0557244 A1 19930825; EP 0557244 B1 19960313; AT E135214 T1 19960315; DE 69301742 D1 19960418; DE 69301742 T2 19960814; DK 0557244 T3 19960401; ES 2084478 T3 19960501; GR 3019314 T3 19960630
DOCDB simple family (application)
EP 93810066 A 19930203; AT 93810066 T 19930203; DE 69301742 T 19930203; DK 93810066 T 19930203; ES 93810066 T 19930203; GR 960400505 T 19960314